The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease
- PMID: 25345265
The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease
Abstract
Objective: To compare the high-resolution computed tomographic (HRCT) findings between systemic sclerosis-associated interstitial lung disease (SSc-ILD) with and without pulmonary arterial hypertension (PAH), as well as to correlate the calculated HRCT scores and the estimated systolic pulmonary artery pressure (sPAP).
Material and method: The medical records of all SSc-ILD patients who presented at the Rheumatology Clinic, Chiang Mai University Hospital were retrospectively reviewed Patients with the availability of echocardiography performed within six months of the corresponding HRCT were included The extent of ground glass, lung fibrosis, and honeycombing were scored The maximum diameter of the main pulmonary artery (MPAD) and ascending aortic diameter (AD) were measured The PAH was defined by sPAP >45 mmHg.
Results: Fifty patients with SSc-ILD diagnosed with HRCT were included Echocardiography identified 19 (38.0%) patients with PAH. The SSc-ILD with PAH had significantly higher mean (SD) lung fibrosis (9.9 [3.6] vs. 7.8 [3.5], p = 0.03), and CT-total scores (20.5 [6.9] vs. 14.9 [6.2], p<0. 01) than those without PAH. In the total group, the CT-total score correlated positively with sPAP (r = 0.384, p<0.01). No significant correlation of MPAD or MPAD/AD with sPAP was found.
Conclusion: SSc-ILD with PAH had more severe lung fibrosis than those without PAH The calculated total HRCT score may be useful to identify PAH in SSc-ILD.
Similar articles
-
High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.J Clin Rheumatol. 2012 Aug;18(5):229-33. doi: 10.1097/RHU.0b013e318261176f. J Clin Rheumatol. 2012. PMID: 22832288
-
Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis.Can Assoc Radiol J. 2010 Dec;61(5):291-6. doi: 10.1016/j.carj.2010.02.006. Epub 2010 Apr 10. Can Assoc Radiol J. 2010. PMID: 20382500
-
Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.Chest. 2007 Apr;131(4):988-92. doi: 10.1378/chest.06-2317. Chest. 2007. PMID: 17426200
-
Evaluation and management approaches for scleroderma lung disease.Ther Adv Respir Dis. 2017 Aug;11(8):327-340. doi: 10.1177/1753465817713680. Epub 2017 Jun 16. Ther Adv Respir Dis. 2017. PMID: 28621173 Free PMC article. Review.
-
Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.Best Pract Res Clin Rheumatol. 2018 Aug;32(4):541-549. doi: 10.1016/j.berh.2019.01.005. Epub 2019 Feb 14. Best Pract Res Clin Rheumatol. 2018. PMID: 31174823 Review.